Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Imac Holdings Inc. (BACK:NASDAQ), powered by AI.
Imac Holdings Inc. is currently trading at $0.07. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Imac Holdings Inc. on Alpha Lenz.
Imac Holdings Inc.'s P/E ratio is -0.0.
“Imac Holdings Inc. trades at a P/E of -0.0 (undervalued) with strong ROE of 283.1%.”
Ask for details →Imac Holdings Inc. is a healthcare company specializing in delivering innovative medical treatment options and services. The company's primary focus lies in advancing regenerative medicine, emphasizing non-invasive and minimally invasive therapies that aim to treat a variety of musculoskeletal disorders and chronic conditions. Imac Holdings operates a network of clinics that provide physical therapy, chiropractic care, and medical treatments designed to improve patient outcomes and enhance quality of life. These clinics serve as an important resource for individuals suffering from sports-related injuries, arthritis, back pain, and other musculoskeletal ailments. By integrating traditional and regenerative medicine, Imac Holdings Inc. plays a pivotal role in the evolving healthcare sector, promoting wellness through cutting-edge therapies and comprehensive care. The company's commitment to innovation and patient care positions it as a notable entity within the global healthcare market.
“Imac Holdings Inc. trades at a P/E of -0.0 (undervalued) with strong ROE of 283.1%.”
Ask for details →Imac Holdings Inc. (ticker: BACK) is a company listed on NASDAQ in the Healthcare sector (Medical Care Facilities). It has approximately 15 employees. Market cap is $107,990.
The current price is $0.069 with a P/E ratio of -0.01x and P/B of -0.02x.
ROE is 283.07% and operating margin is -7804.67%. Annual revenue is $72,050.